Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles

被引:14
作者
Hu, LianDong [1 ]
Jia, Huiqing [1 ]
Luo, ZhaoLiang [1 ]
Liu, Ci [1 ]
Xing, QianBin [1 ]
机构
[1] Hebei Univ, Coll Pharm, Sch Pharm, Baoding 071002, Hebei, Peoples R China
来源
PHARMAZIE | 2010年 / 65卷 / 02期
关键词
P-GLYCOPROTEIN; BIOAVAILABILITY; ENHANCEMENT; SLN;
D O I
10.1691/ph.2010.9241
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, digoxin (DG)-loaded solid lipid nanoparticles (DG-SLNs) were successfully prepared by an ultrasonic and high pressure homogenization method. The particle size and distribution, drug loading capacity, drug entrapment efficiency (EE %), zeta potential, and long-term physical stability of the SLNs were characterized in detail. A pharmacokinetic study was conducted in rabbits after oral administration of 0.25 mg DG in different SLNs and it was found that the relative bioavailability of DG in the SLNs was significantly increased compared with that of a DG solution. The addition of CMC-Na in SLNs also markedly increased the oral absorption of DG. These results indicate that DG absorption is enhanced significantly by employing SLN formulations and SLNs are a potential as an oral delivery carrier for poorly water soluble drugs.
引用
收藏
页码:110 / 113
页数:4
相关论文
共 17 条
[1]   Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems [J].
Balakrishnan, Prabagar ;
Lee, Beom-Jin ;
Oh, Dong Hoon ;
Kim, Jong Oh ;
Lee, Young-Im ;
Kim, Dae-Duk ;
Jee, Jun-Pil ;
Lee, Yong-Bok ;
Woo, Jong Soo ;
Yong, Chul Soon ;
Choi, Han-Gon .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 374 (1-2) :66-72
[2]   Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation [J].
Brocks, DR ;
Betageri, GV .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (08) :1049-1053
[3]  
CHEN Y, 2009, INT J PHARMACEUT, V376, P53
[4]   Solid lipid namoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs [J].
Hu, LD ;
Tang, X ;
Cui, FD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (12) :1527-1535
[5]   Improvement of physicochemical properties of N-4472 Part II: characterization of N-4472 microemulsion and the enhanced oral absorption [J].
Itoh, K ;
Matsui, S ;
Tozuka, Y ;
Oguchi, T ;
Yamamoto, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 246 (1-2) :75-83
[6]   Enhanced Bioavailability of a Poorly Soluble VR1 Antagonist Using an Amorphous Solid Dispersion Approach: A Case Study [J].
Kennedy, Michael ;
Hu, Jack ;
Gao, Ping ;
Li, Lan ;
Ali-Reynolds, Alana ;
Chal, Ben ;
Gupta, Vicki ;
Ma, Chandra ;
Mahajan, Nidhi ;
Akrami, Anna ;
Surapaneni, Sekhar .
MOLECULAR PHARMACEUTICS, 2008, 5 (06) :981-993
[7]   Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles [J].
Li, HouLi ;
Zhao, XiaoBin ;
Ma, YuKun ;
Zhai, GuangXi ;
Li, LingBing ;
Lou, HongXiang .
JOURNAL OF CONTROLLED RELEASE, 2009, 133 (03) :238-244
[8]  
Lucks S., 1996, EP Patent, Patent No. [0605497B1, 0605497]
[9]   Solid lipid nanoparticles -: Production, characterization and applications [J].
Mehnert, W ;
Mäder, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (2-3) :165-196
[10]   Solid lipid nanoparticles (SLN) for controlled drug delivery II. drug incorporation and physicochemical characterization [J].
Schwarz, C ;
Mehnert, W .
JOURNAL OF MICROENCAPSULATION, 1999, 16 (02) :205-213